Found: 51
Select item for more details and to access through your institution.
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The ferric iron chelator 2,2′-dipyridyl attenuates basilar artery vasospasm and improves neurological function after subarachnoid hemorrhage in rabbits.
- Published in:
- Neurological Sciences, 2014, v. 35, n. 9, p. 1413, doi. 10.1007/s10072-014-1730-8
- By:
- Publication type:
- Article
Randomized, Blinded, Placebo- and Positive-Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 1, p. 22, doi. 10.1002/cpdd.352
- By:
- Publication type:
- Article
Iron Chelation Therapy: Past, Present, and Future Prospects.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 3, p. 1
- By:
- Publication type:
- Article
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
- Published in:
- European Journal of Neurology, 2017, v. 24, n. 2, p. 357, doi. 10.1111/ene.13208
- By:
- Publication type:
- Article
Clinical Experience With Deferiprone Treatment for Friedreich Ataxia.
- Published in:
- Journal of Child Neurology, 2016, v. 31, n. 8, p. 1036, doi. 10.1177/0883073816636087
- By:
- Publication type:
- Article
The Iron Chelator and Anticancer Agent Dp44mT Relieves Allergic Inflammation in Mice With Allergic Rhinitis.
- Published in:
- Inflammation, 2018, v. 41, n. 5, p. 1744, doi. 10.1007/s10753-018-0817-4
- By:
- Publication type:
- Article
Physiological study for some blood parameters in patients with major β-Thalassemia in Sulaymaniyah, Kurdistan, Iraq.
- Published in:
- Tikrit Medical Journal, 2016, v. 21, n. 1, p. 187
- By:
- Publication type:
- Article
Wrist Deformity in Children and Adolescents with β-thalassemia on Oral Iron Chelation Therapy.
- Published in:
- Indian Pediatrics, 2019, v. 56, n. 1, p. 41, doi. 10.1007/s13312-019-1465-y
- By:
- Publication type:
- Article
Physiological study for some blood parameters in patients with major β-Thalassemia in Sulaymaniyah, Kurdistan, Iraq.
- Published in:
- Medical Journal of Tikrit, 2016, v. 21, n. 1, p. 187
- By:
- Publication type:
- Article
1475 – Chelation therapy impact and its correlation with the psychological parameters in patients with thalassaemia.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Regulatory Interactions between Iron and Nitric Oxide Metabolism for Immune Defense against Plasmodium falciparum Infection.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 9, p. 1388, doi. 10.1086/319860
- By:
- Publication type:
- Article
The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 10, doi. 10.1111/j.1749-6632.2010.05577.x
- By:
- Publication type:
- Article
Treatment options for thalassemia patients with osteoporosis.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 237, doi. 10.1111/j.1749-6632.2010.05542.x
- By:
- Publication type:
- Article
Humanized mouse models of Cooley's anemia: correct fetal-to-adult hemoglobin switching, disease onset, and disease pathology.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 45, doi. 10.1111/j.1749-6632.2010.05547.x
- By:
- Publication type:
- Article
Cardiovascular MRI in thalassemia major.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 173, doi. 10.1111/j.1749-6632.2010.05571.x
- By:
- Publication type:
- Article
Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 94, doi. 10.1111/j.1749-6632.2010.05573.x
- By:
- Publication type:
- Article
Deferasirox—current knowledge and future challenges.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 87, doi. 10.1111/j.1749-6632.2010.05582.x
- By:
- Publication type:
- Article
Combined iron chelation therapy.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1202, n. 1, p. 79, doi. 10.1111/j.1749-6632.2010.05591.x
- By:
- Publication type:
- Article
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139929
- By:
- Publication type:
- Article
Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085115
- By:
- Publication type:
- Article
Chelation of cadmium by combining deferasirox and deferiprone in rats.
- Published in:
- Toxicology & Industrial Health, 2011, v. 27, n. 4, p. 371, doi. 10.1177/0748233710388451
- By:
- Publication type:
- Article
Incidence of testicular microlithiasis in patients with β-thalassemia major.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Interactions of the pyridine-2-carboxaldehyde isonicotinoyl hydrazone class of chelators with iron and DNA: implications for toxicity in the treatment of iron overload disease.
- Published in:
- Journal of Biological Inorganic Chemistry (JBIC), 2003, v. 8, n. 4, p. 427, doi. 10.1007/s00775-002-0434-3
- By:
- Publication type:
- Article
Editorial.
- Published in:
- Indian Pediatrics, 2016, v. 53, n. 3, p. 199, doi. 10.1007/s13312-016-0819-y
- By:
- Publication type:
- Article
Comparative efficacy and safety of oral iron chelators and their novel combination in children with thalassemia.
- Published in:
- Indian Pediatrics, 2016, v. 53, n. 3, p. 207, doi. 10.1007/s13312-016-0821-4
- By:
- Publication type:
- Article
Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation.
- Published in:
- European Journal of Haematology, 2003, v. 70, n. 6, p. 398, doi. 10.1034/j.1600-0609.2003.00075.x
- By:
- Publication type:
- Article
Deferasirox associated with liver failure and death in a sickle cell anemia patient homozygous for the −1774delG polymorphism in the Abcc2 gene.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 8, p. 1218, doi. 10.1002/ccr3.1040
- By:
- Publication type:
- Article
Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major.
- Published in:
- Frontiers in Pharmacology, 2014, v. 5, p. 1, doi. 10.3389/fphar.2014.00217
- By:
- Publication type:
- Article
Recent developments centered on oraly active iron chelators.
- Published in:
- Thalassemia Reports, 2014, v. 4, n. 2, p. 19, doi. 10.4081/thal.2014.2261
- By:
- Publication type:
- Article
Role of iron metabolism genetic determinants in response to chelation therapy in a cohort of β-thalassemia and sickle cell syndromes Italian patients.
- Published in:
- Thalassemia Reports, 2014, v. 4, n. 2, p. 28, doi. 10.4081/thal.2014.2729
- By:
- Publication type:
- Article
Iron chelating agents for iron overload diseases.
- Published in:
- Thalassemia Reports, 2014, v. 4, n. 2, p. 13, doi. 10.4081/thal.2014.2046
- By:
- Publication type:
- Article
Thalassemia: a dreadful disease turned to a chronic condition.
- Published in:
- Thalassemia Reports, 2013, v. 3, n. 1s, p. 3, doi. 10.4081/thal.2013.s1.e2
- By:
- Publication type:
- Article
A Review on Iron Chelators in Treatment of Iron Overload Syndromes.
- Published in:
- International Journal of Hematology-Oncology & Stem Cell Research, 2016, v. 10, n. 4, p. 239
- By:
- Publication type:
- Article
Iron Chelators Inhibit the Growth and Induce the Apoptosis of Kaposi's Sarcoma Cells and of their Putative Endothelial Precursors.
- Published in:
- Journal of Investigative Dermatology, 2000, v. 115, n. 5, p. 893, doi. 10.1046/j.1523-1747.2000.00119.x
- By:
- Publication type:
- Article
Deferiprone as an oral iron chelator in sickle cell disease.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Combined and alternative iron chelator drugs in treatment of thalassemia major.
- Published in:
- Pakistan Journal of Medical Sciences, 2011, v. 27, n. 3, p. 630
- By:
- Publication type:
- Article
Durable Red Blood Cell Transfusion Independence in a Patient with an MDS/MPN Overlap Syndrome Following Discontinuation of Iron Chelation Therapy.
- Published in:
- Case Reports in Hematology, 2015, v. 2015, p. 1, doi. 10.1155/2015/253294
- By:
- Publication type:
- Article
Iron: the hard player in diabetes pathophysiology.
- Published in:
- Acta Physiologica, 2014, v. 210, n. 4, p. 717, doi. 10.1111/apha.12256
- By:
- Publication type:
- Article
Ciprofloxacin: a novel therapeutic agent for iron overload?
- Published in:
- Turkish Journal of Hematology, 2009, v. 26, n. 3, p. 114
- By:
- Publication type:
- Article
Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.
- Published in:
- Journal of Blood Medicine, 2015, v. 6, p. 197, doi. 10.2147/JBM.S72463
- By:
- Publication type:
- Article
Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 5, p. 504, doi. 10.1111/j.1365-2141.2010.08346.x
- By:
- Publication type:
- Article
ACMT Recommends Against Use of Post-Chelator Challenge Urinary Metal Testing.
- Published in:
- Journal of Medical Toxicology, 2017, v. 13, n. 4, p. 352, doi. 10.1007/s13181-017-0624-6
- Publication type:
- Article
THE USE OF ANABOLIC THERAPY IN PATIENTS WITH BETA-THALASSEMIA MAJOR-INDUCED OSTEOPOROSIS - REVIEW OF THE LITERATURE.
- Published in:
- Farmacia, 2017, v. 65, n. 2, p. 167
- By:
- Publication type:
- Article
Combined Chelation Therapy with Daily Oral Deferiprone and Twice-Weekly Subcutaneous Infusion of Desferrioxamine in Children with β-Thalassemia: 3-Year Experience.
- Published in:
- Acta Haematologica, 2015, v. 133, n. 2, p. 226, doi. 10.1159/000363210
- By:
- Publication type:
- Article
Improvement in Hematopoiesis after Iron Chelation Therapy with Deferasirox in Patients with Aplastic Anemia.
- Published in:
- Acta Haematologica, 2013, v. 129, n. 2, p. 72, doi. 10.1159/000342772
- By:
- Publication type:
- Article
Deferasirox Treatment Interruption in a Transfusion-Requiring Myelodysplastic Patient Led to Loss of Erythroid Response.
- Published in:
- Acta Haematologica, 2010, v. 124, n. 1, p. 46, doi. 10.1159/000314961
- By:
- Publication type:
- Article
Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.
- Published in:
- Journal of Neural Transmission, 2015, v. 122, n. 4, p. 559, doi. 10.1007/s00702-014-1307-y
- By:
- Publication type:
- Article